Search

Pharmaceutical Forms: 50 mg x 60 tablets
150 mg x 60 tablets
150 mg x 120 tablets

Therapeutic Area: Oncology

Active Ingredient: Tucatinib

Pharmaceutical Forms: Hard capsules of 150mg x 28 caps

Therapeutic Area: Antineoplastic + Oncology

Active Ingredient: Vismodegib

Pharmaceutical Forms: 20 mg, 40 mg and 60 mg x 30 coated tablets

Therapeutic Area: Oncology

Active Ingredient: Cabozantinib

Pharmaceutical Forms: 60Mg coated tablets x 120 tablets

Therapeutic Area: Oncology + Uro-Oncology

Active Ingredient: Apalutamide

Pharmaceutical Forms: 40 mg coated tablets x 28 units
30mg coated tablets x 28 units

Therapeutic Area: Oncology

Active Ingredient: Afatinib

Pharmaceutical Forms: 1 glass vial containing 440 mg of lyophilized powder Reconstituted solution 21mg/mL

Therapeutic Area: Oncology

Active Ingredient: Trastuzumab

Pharmaceutical Forms: 5 mg x 30 tablets
10 mg x 30 tablets

Therapeutic Area: Oncology

Active Ingredient: Everolimus

Pharmaceutical Forms: 125 mg capsules x 21
100 mg capsules x 21
75 mg capsules x 21

Therapeutic Area: Oncology

Active Ingredient: Palbociclib

Pharmaceutical Forms: 1 vial containing 0.44 mg/mL

Therapeutic Area: Antineoplastic + Oncology

Active Ingredient: Eribulin Mesylate

Pharmaceutical Forms: 12.5 mg x 28 capsules
25 mg x 28 capsules
50 mg x 28 capsules

Therapeutic Area: Oncology

Active Ingredient: Sunitinib